PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
-10.22%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$3.18B
AUM Growth
+$3.18B
(-36%)
Cap. Flow
-$557M
Cap. Flow
% of AUM
-17.5%
Top 10 Holdings %
Top 10 Hldgs %
52.9%
Holding
144
New
7
Increased
15
Reduced
49
Closed
31
Top Buys
| 1 |
Amylyx Pharmaceuticals
AMLX
|
$39.8M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$39.6M |
| 3 |
Lyra Therapeutics
LYRA
|
$33.5M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$32.6M |
| 5 |
Eli Lilly
LLY
|
$32.4M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$143M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$52.5M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$34.5M |
| 4 |
Penumbra
PEN
|
$31.9M |
| 5 |
Travere Therapeutics
TVTX
|
$30.9M |
Sector Composition
| 1 | Healthcare | 84.05% |
| 2 | Consumer Discretionary | 0.04% |
| 3 | Financials | 0% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amicus Therapeutics
FOLD
$2.34B
| $289M | 9.05% | 26,895,532 -660,313 | -2% | -$7.09M |
|
|
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $192M | 6.03% | 2,866,863 +486,153 | +20% | +$32.6M |
|
|
CERE
3
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $134M | 4.21% | 5,086,727 | – | – |
|
4
Iovance Biotherapeutics
IOVA
$807M
| $131M | 4.09% | 11,826,299 -374,962 | -3% | -$4.14M |
|
|
LIAN
5
DELISTED
LianBio American Depositary Shares
LIAN
| $122M | 3.83% | 56,560,211 +240,251 | +0.4% | +$519K |
|
6
Crinetics Pharmaceuticals
CRNX
$2.92B
| $99.2M | 3.11% | 5,321,032 +157,515 | +3% | +$2.94M |
|
|
GBT
7
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $96.3M | 3.02% | 3,015,054 -877,439 | -23% | -$28M |
|
|
SWTX
8
DELISTED
SpringWorks Therapeutics
SWTX
| $95.2M | 2.98% | 3,867,446 -660,547 | -15% | -$16.3M |
|
|
9
Amylyx Pharmaceuticals
AMLX
$836M
| $68.2M | 2.14% | 3,540,408 +2,066,301 | +140% | +$39.8M |
|
10
Xenon Pharmaceuticals
XENE
$2.98B
| $64.6M | 2.02% | 2,122,535 -288,912 | -12% | -$8.79M |
|
11
MeiraGTx Holdings
MGTX
$587M
| $52.7M | 1.65% | 6,963,277 +15,000 | +0.2% | +$114K |
|
|
12
Lyra Therapeutics
LYRA
$11.5M
| $51.7M | 1.62% | 9,146,730 +5,924,170 | +184% | +$33.5M |
|
|
BLU
13
DELISTED
BELLUS Health Inc.
BLU
| $51.1M | 1.6% | 5,534,169 -2,602,461 | -32% | -$24M |
|
|
RXDX
14
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $47.5M | 1.49% | 1,682,242 -758,340 | -31% | -$21.4M |
|
|
ALBO
15
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $46.9M | 1.47% | 2,360,139 | – | – |
|
|
CINC
16
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $43.7M | 1.37% | 2,319,117 | – | – |
|
|
VBIV
17
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $42.3M | 1.33% | 52,335,002 | – | – |
|
|
SGEN
18
DELISTED
Seagen Inc. Common Stock
SGEN
| $39.6M | 1.24% | +224,000 | New | +$39.6M |
|
19
Veru
VERU
$47.6M
| $39.6M | 1.24% | 3,500,000 -861,998 | -20% | -$9.74M |
|
20
Aldeyra Therapeutics
ALDX
$351M
| $39.5M | 1.24% | 9,903,879 | – | – |
|
21
Neurocrine Biosciences
NBIX
$13.8B
| $38.8M | 1.21% | 397,888 +2,249 | +0.6% | +$219K |
|
22
RAPT Therapeutics
RAPT
$188M
| $34.9M | 1.09% | 1,913,791 -886,171 | -32% | -$16.2M |
|
23
Relay Therapeutics
RLAY
$619M
| $32.5M | 1.02% | 1,943,097 | – | – |
|
|
24
Eli Lilly
LLY
$657B
| $32.4M | 1.02% | +100,000 | New | +$32.4M |
|
25
Cogent Biosciences
COGT
$1.69B
| $27.9M | 0.87% | 3,088,972 -99,778 | -3% | -$900K |
|